Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Ramucirumab × Clear all

Sponsor

Conditions

Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Carcinoma, Hepatocellular 6 Adenocarcinoma 6 Neoplasms 5 Colorectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Urethral Neoplasms 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Ureteral Neoplasms 2 Solid Tumors 2 Sarcoma 2 Non-small Cell Lung Cancer Metastatic 2 Malignant Solid Tumor 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Biliary Tract Neoplasms 2 Thymoma 1 Sarcoma, Synovial 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Metastatic Gastric Adenocarcinoma 1

Interventions

Carboplatin 21 Cisplatin 14 pembrolizumab 12 Paclitaxel 12 Gemcitabine 12 Pemetrexed 9 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 6 durvalumab 5 Fluorouracil 5 Docetaxel 5 Cyclophosphamide 5 Axitinib 5 Albumin-Bound Paclitaxel 5 osimertinib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Ipilimumab 4 Erlotinib Hydrochloride 4 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 vosaroxin 2 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡